Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas

Mucosal Healing Study in Crohn's Disease (CD)

NCT00297648 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's Disease

NCT00552058 ·Status: COMPLETED ·Phase: PHASE3

Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab

NCT00308581 ·Status: COMPLETED ·Phase: PHASE3

EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment

NCT01582568 ·Status: TERMINATED

Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease

NCT00349752 ·Status: TERMINATED ·Phase: PHASE3

Study to Look at Benefit of Surgical Drainage Before Beginning Medical Therapy for Crohns Perianal Fistulas

NCT01145365 ·Status: COMPLETED ·Phase: NA

Maintenance Study of Certolizumab Pegol (CZP) in Crohn's Disease

NCT00329550 ·Status: COMPLETED ·Phase: PHASE2

Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

NCT01190410 ·Status: COMPLETED ·Phase: PHASE2

Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed Infliximab

NCT00307931 ·Status: TERMINATED ·Phase: PHASE3

A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease

NCT04643483 ·Status: WITHDRAWN ·Phase: PHASE3

CUP Certolizumab Pegol (CDP-870) in Adults Suffering From Crohn's Disease (CD)

NCT03559660 ·Status: NO_LONGER_AVAILABLE

A Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo)

NCT00152490 ·Status: COMPLETED ·Phase: PHASE3

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]

NCT00160524 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease Who Have Failed or Are Intolerant to Tumor Necrosis Factor (TNF) Antagonist Therapy (UNITI-1)

NCT01369329 ·Status: COMPLETED ·Phase: PHASE3

Anal Crohn Fistula Surgery

NCT01388257 ·Status: UNKNOWN ·Phase: NA

Visilizumab for Treatment of Perianal Fistulas in Crohn's Disease

NCT00267709 ·Status: COMPLETED ·Phase: PHASE2

Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy

NCT01053559 ·Status: COMPLETED ·Phase: NA

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

NCT00152425 ·Status: COMPLETED ·Phase: PHASE3

Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)

NCT00329420 ·Status: COMPLETED ·Phase: PHASE2

Optimizing Cimzia in Crohn's Patients

NCT01024647 ·Status: UNKNOWN ·Phase: PHASE4

A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's Disease

NCT05347095 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Cimzia for the Treatment of Ulcerative Colitis

NCT01090154 ·Status: COMPLETED ·Phase: PHASE2

A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease

NCT00160706 ·Status: COMPLETED ·Phase: PHASE3

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease

NCT00269841 ·Status: COMPLETED ·Phase: PHASE3

Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease

NCT00004941 ·Status: COMPLETED ·Phase: PHASE3